Skip to main content

Table 7 Comparison of neutrophil expression of CD11b, CD15, CD16, CD18, and CD177 among MPD patients, healthy subjects, and healthy subjects given G-CSF

From: Gene and microRNA analysis of neutrophils from patients with polycythemia vera and essential thrombocytosis: down-regulation of micro RNA-1 and -133a

 

Healthy Subjects

(n = 43)

All MPD Patients

(n = 24)

Polycythemia Vera

(n = 11)

Essential Thrombocytosis

(n = 13)

G-CSF-Treated Subjects

(n = 27)

% Reactive cells

CD11b

55 ± 26

54 ± 28

66 ± 27

44 ± 26†

64 ± 24

CD15

21 ± 25

50 ± 31*†

51 ± 31*†

49 ± 33*†

23 ± 29

CD16

81 ± 22

82 ± 19

83 ± 24

82 ± 16

89 ± 5

CD18

48 ± 33

73 ± 26*

73 ± 30*

73 ± 23*

62 ± 35

CD177

53 ± 23

59 ± 28†

59 ± 29†

58 ± 27†

82 ± 26*

Mean Fluorescence Intensity

CD11b

182 ± 51

187 ± 107

171 ± 100

200 ± 115

155 ± 67

CD15

480 ± 284

374 ± 236

373 ± 265

377 ± 221

441 ± 443

CD16

2,946 ± 1,345

2,580 ± 1,138†

2,410 ± 1,430†

2,725 ± 853†

890 ± 336*

CD18

451 ± 300

250 ± 81*

267 ± 100

237 ± 61*

253 ± 107*

CD177

625 ± 383

575 ± 267†

587 ± 251†

566 ± 290†

2,012 ± 1088*

  1. * p < 0.05 compared to healthy subjects
  2. † p < 0.05 compared to subjects given G-CSF
  3. Fluor = fluorescence